EBR Systems (ASX:EBR) submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its WiSE cardiac resynchronization therapy system, according to a Monday filing with the Australian bourse.

The reimbursement program aims to facilitate hospital adoption of medical technologies that demonstrate substantial clinical improvement for patients but are not yet fully incorporated into standard Medicare payment rates, the filing said.

The program is expected to be effective from Oct. 1, according to the filing.